ACE Inhibitors and ARBs
ACE inhibitors and ARBs showed no association with reduced stroke recurrence in non-AF patients. ACE inhibitors and ARBs showed MACE or mortality benefit despite lacking stroke-specific benefit in the cohort. The study does not confirm ACE…
1 sources - 4 claims
ACE inhibitors and ARBs showed no association with reduced stroke recurrence in non-AF patients. ACE inhibitors and ARBs showed MACE or mortality benefit despite lacking stroke-specific benefit in the cohort. The study does not confirm ACE inhibitor effectiveness for stroke recurrence shown in prior trial contexts. The absence of stroke-specific benefit from ACEi or ARB may be due to concurrent secondary-prevention therapies, polypharmacy, or unmeasured hypotension.